{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:12:35Z","timestamp":1790874755919,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background. \u2003Persistent aminotransferase elevations are common in human immunodeficiency virus (HIV)\u2013infected patients on antiretroviral therapy (ART), including those without hepatitis B or C coinfection, but their clinical significance is unknown.<\/jats:p>\n               <jats:p>Methods. \u2003HIV-infected adults with aminotransferase levels elevated above the upper limit of normal for \u22656 months while receiving ART, and without chronic viral hepatitis or other known causes of chronic liver disease, underwent a detailed metabolic assessment and liver biopsy.<\/jats:p>\n               <jats:p>Results. \u2003Sixty-two HIV-infected subjects completed the study. Forty (65%) had clinically significant liver pathology, including 34 (55%) with nonalcoholic steatohepatitis (NASH) and 11 (18%) with bridging fibrosis, 10 of whom also had NASH. Nonspecific abnormalities alone were seen in 22 (35%) subjects, including mild steatosis, mild to moderate inflammation, and evidence of drug adaptation. Insulin resistance, obesity, and the presence of either of 2 minor alleles in the PNPLA3 gene were significantly associated with increased risk of NASH and fibrosis. NASH and\/or fibrosis were not associated with duration of HIV infection or ART, specific antiretroviral drugs, history of opportunistic infection, immune status, or duration of aminotransferase elevation.<\/jats:p>\n               <jats:p>Conclusions. \u2003HIV-infected adults with chronic aminotransferase elevations while receiving ART have a high rate of liver disease. Noninvasive testing can help identify liver disease in such patients, but liver biopsy is necessary to definitively identify those at risk for liver disease progression and complications. Longitudinal follow-up of this cohort will better characterize the natural history of aminotransferase elevations in this population and identify noninvasive biomarkers of liver disease progression.<\/jats:p>","DOI":"10.1093\/cid\/civ101","type":"journal-article","created":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T05:28:59Z","timestamp":1423891739000},"page":"1569-1578","source":"Crossref","is-referenced-by-count":78,"title":["Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1\u2013Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy"],"prefix":"10.1093","volume":"60","author":[{"given":"Caryn G.","family":"Morse","sequence":"first","affiliation":[{"name":"National Institutes of Health (NIH) Clinical Center 1 Critical Care Medicine Department, AIDS Section ,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoregulation 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Matthews","sequence":"additional","affiliation":[{"name":"National Institutes of Health (NIH) Clinical Center 1 Critical Care Medicine Department, AIDS Section ,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Proschan","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases (NIAID) 3 Biostatistics Research Branch ,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Thomas","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology, 4 NIH Clinical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Gharib","sequence":"additional","affiliation":[{"name":"Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mones","family":"Abu-Asab","sequence":"additional","affiliation":[{"name":"Histology Core, National Eye Institute, Bethesda, Maryland 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Orenstein","sequence":"additional","affiliation":[{"name":"Baystate Medical Center 7 , Springfield, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Engle","sequence":"additional","affiliation":[{"name":"8 Laboratory of Infectious Disease, NIAID, Bethesda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Hu","sequence":"additional","affiliation":[{"name":"Leidos Biomedical Research, Inc, Frederick 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lempicki","sequence":"additional","affiliation":[{"name":"Leidos Biomedical Research, Inc, Frederick 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Hadigan","sequence":"additional","affiliation":[{"name":"Laboratory of Immunoregulation 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[{"name":"Laboratory of Pathology, National Cancer Institute 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, NIDDK, Bethesda, Maryland 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Kovacs","sequence":"additional","affiliation":[{"name":"National Institutes of Health (NIH) Clinical Center 1 Critical Care Medicine Department, AIDS Section ,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,13]]},"reference":[{"key":"2024111411392912100_CIV101C1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"2024111411392912100_CIV101C2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s10620-007-9999-6","article-title":"The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections","volume":"53","author":"Sterling","year":"2008","journal-title":"Dig Dis Sci"},{"key":"2024111411392912100_CIV101C3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cgh.2009.09.025","article-title":"Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons","volume":"8","author":"Crum-Cianflone","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024111411392912100_CIV101C4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3851\/IMP1783","article-title":"High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda","volume":"16","author":"Stabinski","year":"2011","journal-title":"Antivir Ther"},{"key":"2024111411392912100_CIV101C5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.23679","article-title":"Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV\/hepatitis C virus-induced liver fibrosis","volume":"52","author":"Tuyama","year":"2010","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/hep.22665","article-title":"Liver damage underlying unexplained aminotransferase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy","volume":"49","author":"Ingiliz","year":"2009","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/MCG.0b013e318264181d","article-title":"Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse","volume":"47","author":"Sterling","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"2024111411392912100_CIV101C8","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/hep.23716","article-title":"Clinical syndromes and consequences of antiretroviral-related hepatotoxicity","volume":"52","author":"Nunez","year":"2010","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C9","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"2024111411392912100_CIV101C10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/cid\/cis919","article-title":"Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of HBV or HCV co-infection. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study","volume":"56","author":"Kovari","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2024111411392912100_CIV101C11","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1128\/JCM.40.12.4576-4580.2002","article-title":"Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay","volume":"40","author":"Engle","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2024111411392912100_CIV101C12","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024111411392912100_CIV101C13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2024111411392912100_CIV101C17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00132577-200512000-00018","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement: executive summary","volume":"4","author":"Grundy","year":"2005","journal-title":"Crit Pathw Cardiol"},{"key":"2024111411392912100_CIV101C18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0168-8278(97)80288-7","article-title":"Noninvasive in vivo quantitative assessment of fat content in human liver","volume":"27","author":"Ricci","year":"1997","journal-title":"J Hepatol"},{"key":"2024111411392912100_CIV101C19","doi-asserted-by":"crossref","DOI":"10.1117\/12.878063","article-title":"Fully automated adipose tissue measurement on abdominal CT","author":"Yao","year":"2011"},{"key":"2024111411392912100_CIV101C20","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"2024111411392912100_CIV101C21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","article-title":"Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes","volume":"83","author":"Yuan","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2024111411392912100_CIV101C24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2024111411392912100_CIV101C25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.atherosclerosis.2006.12.018","article-title":"Ethnic differences in the ability of triglyceride levels to identify insulin resistance","volume":"196","author":"Sumner","year":"2008","journal-title":"Atherosclerosis"},{"key":"2024111411392912100_CIV101C26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2337\/diacare.25.8.1371","article-title":"Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers","volume":"25","author":"Marques-Vidal","year":"2002","journal-title":"Diabetes Care"},{"key":"2024111411392912100_CIV101C27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"Genomes Project Consortium","year":"2012","journal-title":"Nature"},{"key":"2024111411392912100_CIV101C28","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","article-title":"Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients","volume":"94","author":"Daniel","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2024111411392912100_CIV101C29","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2006.05.008","article-title":"Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study","volume":"45","author":"de Ledinghen","year":"2006","journal-title":"J Hepatol"},{"key":"2024111411392912100_CIV101C30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"2024111411392912100_CIV101C31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.24491","article-title":"The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study","volume":"54","author":"Bhala","year":"2011","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"Baffy","year":"2012","journal-title":"J Hepatol"},{"key":"2024111411392912100_CIV101C33","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C34","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.296.7.844","article-title":"Metabolic and skeletal complications of HIV infection: the price of success","volume":"296","author":"Morse","year":"2006","journal-title":"JAMA"},{"key":"2024111411392912100_CIV101C35","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QAI.0b013e318198a88a","article-title":"Nonalcoholic fatty liver disease among HIV-infected persons","volume":"50","author":"Crum-Cianflone","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024111411392912100_CIV101C36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2024111411392912100_CIV101C37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"2024111411392912100_CIV101C38","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/hep.26767","article-title":"Association between the PNPLA3 (rs738409 C&gt;G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data","volume":"59","author":"Trepo","year":"2014","journal-title":"Hepatology"},{"key":"2024111411392912100_CIV101C39","doi-asserted-by":"crossref","first-page":"G66","DOI":"10.1152\/ajpgi.00335.2013","article-title":"Metabolic profiling reveals that Pnpla3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cells","volume":"307","author":"Min","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2024111411392912100_CIV101C40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ajg.2014.32","article-title":"Risk factors for fatty liver in the multicenter AIDS cohort study","volume":"109","author":"Price","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2024111411392912100_CIV101C41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1086\/603559","article-title":"Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study","volume":"49","author":"Kovari","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/60\/10\/1569\/16787409\/civ101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/60\/10\/1569\/16787409\/civ101.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:46:09Z","timestamp":1731584769000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/60\/10\/1569\/338465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,13]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,2,13]]},"published-print":{"date-parts":[[2015,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/civ101","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,5,15]]},"published":{"date-parts":[[2015,2,13]]}}}